Content » Vol 95, Issue 3

Short communication

Comparative Cut-off Value Setting of Pruritus Intensity in Visual Analogue Scale and Verbal Rating Scale

Makiko Kido-Nakahara1, Norito Katoh2, Hidehisa Saeki3, Hitoshi Mizutani4, Akihito Hagihara5, Satoshi Takeuchi1, Takeshi Nakahara1, Koji Masuda2, Risa Tamagawa-Mineoka2, Hidemi Nakagawa3,Yoichi Omoto4, Kimiko Matsubara4 and Masutaka Furue1

Departments of Dermatology, Graduate School of Medical Sciences, 1Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, 2Kyoto Prefectural University of Medicine, Kyoto, Departments of Dermatology, 3School of Medicine, Jikei University, Tokyo, 4Graduate School of Medicine, Mie University, Mie, and 5Department of Health Services Management and Policy, Graduate School of Medicine, Kyushu University, Fukuoka, Japan. E-mail: macky@dermatol.med.kyushu-u.ac.jp

Accepted Sep 16, 2014; Epub ahead of print Sep 17, 2014

There are several established methods to estimate the intensity of pruritus quantitatively, including the visual analogue scale (VAS) and verbal rating scale (VRS). High reliability and concurrent validity were recently reported for the VAS and VRS for pruritus assessment (1, 2). Although VAS is one of the most widely distributed methods to estimate the intensity of pruritus, it also has yet to be cleared whether same scores of VAS obtained from different ethnic groups could be considered as same pruritus intensity, and the factors influencing the pruritus scores. Reich et al. (1) recently proposed VAS categories: cut-off values of (4-7-9) to distinguish mild, moderate, severe, and very severe pruritus on the basis of a detailed analysis1. The authors also reported some differences between Caucasian and Asian subjects.

10102.png

1VAS = 0: no pruritus; VAS > 0–< 4: mild pruritus; VAS ≥ 4–< 7: moderate pruritus; VAS ≥ 7–< 9: severe pruritus; VAS ≥ 9: very severe pruritus.

The factors influencing pain intensity, which is also a subjective symptom, are well studied. Although pruritus is believed to be influenced by factors such as age, sex, and ethnic background as well as pain, these aspects have not yet been addressed.

Based on the report by Reich et al., we analysed the cut-off value setting of pruritus intensity by comparing VAS with VRS in 949 Japanese subjects to address the effect of ethnic demographic and regional influence on the VAS and VRS.

PATIENTS AND METHODS

Consecutive patients who visited dermatology depart­ments at 4 university hospitals, Kyoto Prefectural University of Medicine (KPUM), Mie University (Mie U.), Jikei University (Jikei U.) and Kyushu University (Kyushu U.) from April 2012 to January 2013 were recruited in this study. The inclusion criteria were as follows: informed consent obtained from a patient to participate in the study, age > 10 years. A total of 949 patients with various dermatological diseases were recruited (Table I). The diagnoses of these patients were categorised into 5 groups: “atopic dermatitis (AD)”; “eczema and dermatitis except AD”; “urticaria, prurigo, and pruritus”; “psoriasis and other keratosis”; and “others”. The rates of each disease varied among facilities. Patients were instructed to rate their perception of pruritus within a 24-h period using the horizontal VAS (3), followed by the 5-point VRS. The 5-point VRS consists of a list of phrases that describe increasing levels of pruritus intensity: no pruritus (0 points), mild pruritus (1 point), moderate pruritus (2 points), severe pruritus (3 points), and very severe pruritus (4 points).

Table I. Characteristics of the study population at 4 university hospitals

Total

KPUM

Mie U.

Jikei U.

Kyushu U.

Patients, n

949

248*

108*

277

316

Age, years ± SD

52.6 ± 19.3

57.8 ± 22.2

57.9 ± 18.1

49.1 ± 16.8

49.8 ± 18.0

Male:female

446:503

119:129

54:54

145:132

128:188

Male, %

47.0

48.0

50.0

52.3

40.5

Diseases, %

AD

181 (19.1)

29 (11.7)

22 (20.4)

70 (25.3)

60 (19.0)

Eczema

225 (23.7)

94 (37.9)

26 (24.1)

66 (23.8)

39 (12.3)

Urticaria

120 (12.6)

47 (19.0)

17 (15.7)

22 (7.9)

34 (10.8)

Psoriasis

141 (14.9)

10 (4.0)

9 (8.3)

85 (30.7)

37 (11.7)

Others

282 (29.7)

68 (27.4)

34 (31.5)

34 (12.3)

146 (46.2)

Values derived using ANOVA with Dunnett’s post hoc test. *p < 0.001 vs. Kyushu U.

The Pearson chiχ2-test with standardised Pearson residual analysis. χ2=194.70, (df)=12, p < 0.001; ▲p < 0.05, significantly high; p < 0.05, significantly low.

The categories – or bands – of the VAS were defined on the basis of the horizontal VAS, as previously described (1, 4). Multiple regression analysis was performed for VAS and VRS scores using 4 explanatory variables (age, sex, disease, and site) as independent variables. Dummy variables were introduced for sex (male: 0; female: 1), disease [AD: (1,0,0,0); eczema: (0,1,0,0); urticaria: (0,0,1,0); psoriasis: (0,0,0,0); other: (0,0,0,1)], and site [KPUM: (1,0,0); Mie U.: (0,1,0); Jikei U.: (0,0,1); Kyushu U.: (0,0,0)]. The following tests were used: 1-way analysis of variance (ANOVA) with Dunnett’s post hoc test, Pearson’s chi-square test with standardised Pearson residual analysis, κ coefficient analysis, and multiple regression analysis.

RESULTS

We calculated the mean, median, and mode of VRS scoring for each VAS score and concluded that the delineation between mild and moderate pruritus should occur at 3 or 4 points on the VAS, the delineation between moderate and severe pruritus should occur at 6 or 7 points, and the delineation between severe and very severe pruritus should occur at 8 or 9 points (Table SI2). Using these cut-off scores, we calculated the κ coefficient to find a suitable VAS categorisation. For all patients, the most suitable set of VAS bands were (3-7-9) and corresponds to a κ coefficient of 0.64 (Table SII2). For male and female subjects, both (3-7-9) and (4-7-9) were equally suitable. However, we proposed a final set of bands for VAS of (3-7-9) on the basis of data obtained from all patients, which was consistent with that reported by Reich et al. (1) in a population of Caucasian patients.

We analysed the relationship between VAS or VRS and age, sex, disease, and site using multiple regression analysis to determine factors that may influence VAS or VRS scores (Table II). Neither age nor sex had any effect on the VAS or VRS scores. With respect to disease category, patients with AD, eczema, and urticaria rated their itch intensity significantly higher than patients with psoriasis. We also observed that patients at Jikei U. rated pruritus intensity significantly higher than those at Kyushu U. (p < 0.05 for VAS, p < 0.0001 for VRS), suggesting that there are regional differences in the expression of itch intensity.

Table II. Factors affecting visual analogue scale (VAS) or verbal rating scale (VRS) identified by multiple regression analysis

Stratified factor

Unstandardised partial regression coefficient (B)

VAS (Adjusted R2 = 0.1638)

VRS (Adjusted R2 = 0.1764)

Age

0.016

–0.001

Gender

–3.273

0.094

Disease (reference category: Psoriasis)

AD

20.616*

0.841*

Eczema

24.718*

0.971*

Urticaria

16.467*

0.656*

Others

–3.754

–0.186

Facility (reference category: Kyushu U.)

KPUM

0.157

–0.067

Mie U.

5.292

0.162

Jikei U.

5.778*

0.259*

Constant

24.022*

1.123*

*p < 0.05.

KPUM: Kyoto Prefectural University of Medicine.

DISCUSSION

The primary aim of this study was to define the cut-off value setting of pruritus intensity for VAS categorisation in 949 Japanese patients by using VRS scores. Our results suggest that VAS cut-off values (3-7-9) composed the most suitable set for Japanese patients and corresponded to those determined for Caucasian patients in a previous study by Reich et al. (1). These authors concluded that the cut-off values (3-7-9) were the most appropriate in Caucasians, although they observed that suitable cut-off values changed to (4-7-9) when Japanese patients were included. Since the present study was conducted to revisit the evaluation of this discrepancy by enrolling a large number of Japanese patients, our results support (3-7-9) as the most appropriate set of cut-off values for both Caucasian and Japanese patients. These results indicate that ethnic differences may be negligible when VAS and VRS are used to assess pruritus. Our results were useful for the evaluation of the clinical investigation in which the endpoint is itch intensity.

Our second aim was to analyse whether age, sex and geographic location influence VAS or VRS scores. In our study, patients at Jikei U. rated pruritus intensity significantly higher than those at Kyushu U. (p < 0.05 for VAS, p < 0.0001 for VRS). No significant influence of age or sex was observed in this study. Several factors may explain the observed regional differences. First, we could not exclude the influence of severity of diseases between patients at Jikei U. and Kyushu U. The second potential confounding factor is stress levels. Lederbogen et al. (5) recently showed that city living and urban upbringing significantly affect neural social stress processing in humans. In general, perceived stress is widely recognised to trigger or enhance pruritus (6, 7). Moreover, we also cannot exclude the possibility that pruritus rating may be influenced by other cultural and regional aspects that have not yet been determined. Further research is needed to reveal the factors influencing VAS and VRS scores.

In conclusion, the VAS and VRS appear to be valu­able methods for pruritus evaluation, irrespective of ethnic differences.

ACKNOWLEDGEMENTS

This work was supported in part by a research grant from The Ministry of Health, Labour and Welfare, Japan.

10129.png

2http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-1972

REFERENCES

1. Reich A, Heisig M, Phan NQ, Taneda K, Takamori K, Takeuchi S, et al. Visual analogue scale: evaluation of the instrument for the assessment of pruritus. Acta Derm Venereol 2012; 92: 497–501.

2. Phan NQ, Blome C, Fritz F, Gerss J, Reich A, Ebata T, et al. Assessment of pruritus intensity: prospective study on validity and reliability of the visual analogue scale, numerical rating scale and verbal rating scale in 471 patients with chronic pruritus. Acta Derm Venereol 2012; 92: 502–507.

3. Furue M, Ebata T, Ikoma A, Takeuchi S, Kataoka Y, Takamori K, et al. Verbalizing extremes of the visual analogue scale for pruritus: a consensus statement. Acta Derm Venereol 2013; 93: 214–215.

4. Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659–664.

5. Lederbogen F, Kirsch P, Haddad L, Streit F, Tost H, Schuch P, et al. City living and urban upbringing affect neural social stress processing in humans. Nature 2011; 474: 498–501.

6. Tran BW, Papoiu AD, Russoniello CV, Wang H, Patel TS, Chan YH, Yosipovitch G. Effect of itch, scratching and mental stress on autonomic nervous system function in atopic dermatitis. Acta Derm Venereol 2010; 90: 354–361.

7. Yamamoto Y, Yamazaki S, Hayashino Y, Takahashi O, Tokuda Y, Shimbo T, et al. Association between frequency of pruritic symptoms and perceived psychological stress: a Japanese population-based study. Arch Dermatol 2009; 145: 1384–1388.

Supplementary content
Table SI
Table SII